Drew Weissman
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- RNA Interference and Gene Delivery 85
- Advanced biosensing and bioanalysis techniques 17
- Immunology 84
- Immunotherapy and Immune Responses 36
- Immune Cell Function and Interaction 31
- Co-authors
- Katalin Karikó (31 shared papers)Norbert Pardi (48 shared papers)Michael J. Hogan (5 shared papers)Houping Ni (36 shared papers)Frederick Porter (1 shared paper)Hiromi Muramatsu (25 shared papers)Michael Buckstein (1 shared paper)Mohamad‐Gabriel Alameh (60 shared papers)
- Journals
- The Journal of Immunology (14 papers)Nature Communications (12 papers)npj Vaccines (11 papers)Journal of the American Chemical Society (9 papers)Journal of Virology (8 papers)
- Partner nations
- United StatesChinaBotswana
In The Last Decade
Drew Weissman
228 papers receiving 24.9k citations
Drew Weissman's Hit Papers
Peers
Comparison fields: 5 of 174
- Virology 2.2k
- Immunology 7.5k
- Infectious Diseases 5.8k
- Molecular Biology 14.6k
- Animal Science and Zoology 1.3k
Countries citing papers authored by Drew Weissman
This map shows the geographic impact of Drew Weissman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Weissman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Weissman more than expected).
Fields of papers citing papers by Drew Weissman
This network shows the impact of papers produced by Drew Weissman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Weissman. The network helps show where Drew Weissman may publish in the future.
Co-authors
The 25 scholars most cited alongside Drew Weissman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | mRNA vaccines — a new era in vaccinology Hit paper breakdown → | 2018 | 3197 |
| 2 | Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA Hit paper breakdown → | 2005 | 1891 |
| 3 | Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability Hit paper breakdown → | 2008 | 1311 |
| 4 | mRNA vaccines for infectious diseases: principles, delivery and clinical translation Hit paper breakdown → | 2021 | 1006 |
| 5 | mRNA Is an Endogenous Ligand for Toll-like Receptor 3 Hit paper breakdown → | 2004 | 859 |
| 6 | Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes Hit paper breakdown → | 2015 | 723 |
| 7 | Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA Hit paper breakdown → | 2011 | 669 |
| 8 | CAR T Cells Produced in vivo to Treat Cardiac Injury Hit paper breakdown → | 2023 | 655 |
| 9 | Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation Hit paper breakdown → | 2010 | 495 |
| 10 | Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages Hit paper breakdown → | 1999 | 490 |
| 11 | An ionizable lipid toolbox for RNA delivery Hit paper breakdown → | 2021 | 446 |
| 12 | Nanomaterial Delivery Systems for mRNA Vaccines Hit paper breakdown → | 2021 | 417 |
| 13 | Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation Hit paper breakdown → | 1996 | 394 |
| 14 | 2002 | 372 | |
| 15 | Recent advances in mRNA vaccine technology Hit paper breakdown → | 2020 | 360 |
| 16 | 2004 | 353 | |
| 17 | Tuberculosis and lung damage: from epidemiology to pathophysiology Hit paper breakdown → | 2018 | 342 |
| 18 | Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration Hit paper breakdown → | 2021 | 317 |
| 19 | Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor Hit paper breakdown → | 1997 | 306 |
| 20 | Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge Hit paper breakdown → | 2017 | 279 |
About Drew Weissman
Drew Weissman is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Virology and Epidemiology, having authored 233 papers that have together received 25.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (85 papers), HIV Research and Treatment (49 papers), Immunotherapy and Immune Responses (36 papers), Immune Cell Function and Interaction (31 papers), Virus-based gene therapy research (24 papers), Animal Virus Infections Studies (20 papers), SARS-CoV-2 and COVID-19 Research (19 papers) and Advanced biosensing and bioanalysis techniques (17 papers). The work is most often cited by research in Virology (2.2k citations), Immunology (7.5k citations), Infectious Diseases (5.8k citations), Molecular Biology (14.6k citations) and Animal Science and Zoology (1.3k citations). Drew Weissman has collaborated with scholars based in United States, China and Botswana. Frequent co-authors include Katalin Karikó, Norbert Pardi, Michael J. Hogan, Houping Ni, Frederick Porter, Hiromi Muramatsu, Michael Buckstein, Mohamad‐Gabriel Alameh, John Capodici and Kathryn A. Whitehead. Their work appears in journals such as The Journal of Immunology, Nature Communications, npj Vaccines, Journal of the American Chemical Society and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.